menu
    • menu

    Company profile for BAKX Therapeutics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bakx Therapeutics is an oncology company focused on the apoptosis pathway. We create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations. We create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial ap...
    Bakx Therapeutics is an oncology company focused on the apoptosis pathway. We create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations. We create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations. We have built an integrated & iterative platform based on knowledge, experimentation, and simulation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BAKX TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8 N Front St, Kingston, NY 12401, United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bakxtx.com/wp-content/uploads/2022/03/BW-reprint-031522-Bakx.pdf
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bakxtx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/bakxtx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BAKX to shut down after ‘scientific challenges’ and financing doldrums
    BAKX to shut down after ‘scientific challenges’ and financing doldrums

    11 Jul 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/bakx-therapeutics-to-shut-down-after-scientific-challenges-and-financing-doldrums/

    Kyle LaHucik ENDPTS
    11 Jul 2023
    Share Share
    BAKX Welcomes Dr. Marina Konopleva to Its Scientific Advisory Board
    BAKX Welcomes Dr. Marina Konopleva to Its Scientific Advisory Board

    16 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221116005324/en

    BUSINESSWIRE
    16 Nov 2022
    Share Share
    BAKX nets more cash for its 'Thelma and Louise' approach to cancer cell death
    BAKX nets more cash for its 'Thelma and Louise' approach to cancer cell death

    18 Nov 2021

    // Nicole DeFeudis ENDPTS

    https://endpts.com/months-after-massive-ipsen-deal-bakx-therapeutics-nets-more-cash-for-its-thelma-and-louise-approach-to-cancer-cell-death/

    Nicole DeFeudis ENDPTS
    18 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search